The article analyzes how different therapy regimens affect the treatment effectiveness in patients with early and late rheumatoid arthritis over a year-long observation period.
Data was collected through continuous copying from case histories of hospital patients, focusing on anti-inflammatory therapy and related treatments.
Effectiveness was measured using the DAS 28 index, which assesses disease activity based on joint pain, swelling, laboratory results, and patient health perceptions.